Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
On April 29 the National Pharmaceutical Council (NPC) hosted a virtual panel discussion on state decisions to implement budget caps and the strategies, challenges, and the relevance of these decisions on patient health. Twenty four percent of states currently use budget caps to help limit annual health spending growth, and that percentage continues to increase.
Researchers at the National Pharmaceutical Council (NPC) and Discern Health published an article in the Journal of Clinical Pathways (JCP) that offers recommendations to the Biden administration to make cancer care more patient-centered. The researchers suggest that the key to elevating patient voices is using the right tools when developing a value-based payment (VBP) model: patient-reported measures (PRMs), tools that capture patients’ voices related to their care experiences and outcomes, and patient-reported performance measures (PR-PMs), tools that translate PRM responses into metrics to compare health care performance and track changes over time.
NPC Board Chair and BMS SVP Michael Ryan reflects on the biopharmaceutical industry's role in solving global health challenges and how to address misunderstandings about what it takes to bring innovative medicines to market.
Thanks to a recent IRS rule, high-deductible health plans with health savings accounts can now cover an expanded list of preventive services and medications before patients meet their plan’s annual out-of-pocket deductible. While still early in the adoption, this policy change — and others — can help remove disincentives for patients to receive high-value care.
In his editorial in the American Journal of Managed Care®, NPC Interim President and CEO Robert Dubois, PhD, MD, says we need to address social determinants of health (SDOH) and improve patients’ lives through approaches based on strong data. Given the clear association between SDOH and health outcomes, “building the evidence base for SDOH must be job one. Good policy can only be led by good data.”
Health care policy experts gathered for a panel discussion at the AcademyHealth 2021 Datapalooza and National Health Policy Conference in February to discuss key questions regarding government funding for research, vaccine pricing, incentives and innovation. The panel session, “If the NIH Funds the Research, Should There Be a 'Government Discount?” was moderated by National Pharmaceutical Council (NPC) Interim President and CEO Robert Dubois, and featured Northwestern University’s Craig Garthwaite, Brigham and Women's Hospital’s Aaron Kesselheim, University of Minnesota’s Stephen Parente, and the Milken Institute’s Kristin Schneeman.